2022 ku post san antonio review | breast cancer risk assessment and reduction: what's new
Published 2 years ago • 239 plays • Length 28:05Download video MP4
Download video MP3
Similar videos
-
31:32
2022 ku post san antonio review | early-stage hormone breast cancer: optimizing systemic therapy
-
24:34
2022 ku post san antonio review | updates in locoregional therapy
-
30:10
2022 ku post san antonio review | metastatic her2 positive breast cancer: novel treatment approaches
-
46:12
2022 ku post san antonio review | monday morning practice implications: q&a and case discussion 1
-
46:00
2022 ku post san antonio review | monday morning practice implications: q&a and case discussion 2
-
23:20
2022 ku post san antonio review | (neo)adjuvant therapy for triple negative breast cancer
-
58:39
high-risk patient breast cancer case panel discussion | 2022 best of breast conference
-
0:49
san antonio breast cancer symposium 2022 highlights
-
0:57
breast cancer risk assessment overview
-
1:25
breast cancer molecular testing – more tools in the toolbox: 2023 ku breast cancer year in review
-
28:02
2022 west oncology conference | breast cancers | early-stage
-
3:03
radiation after lumpectomy – determining who benefits: 2023 ku breast cancer year in review
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
57:59
breast cancer patient perspectives panel discussion | 2022 best of breast conference
-
1:00
highlights from the san antonio breast cancer symposium 2022
-
0:56
the san antonio breast cancer symposium (sabcs) 2022
-
14:04
dr. nicholas turner | san antonio breast cancer symposium 2022 | general session
-
22:57
2022 west oncology conference | breast cancers | metastatic